Continuous glucose monitoring system using an intravascular, optical fluorescence-based sensor to support clinical implementation of tight glycemic control (TGC) in the intensive care unit (ICU)
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of GlySure plus 4812 other startups.
